-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Poseida Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q3 2024.
- Poseida Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $19.7M.
- Poseida Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$62.5M, a 54.3% increase year-over-year.
- Poseida Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$130M, a 116% decline from 2022.
- Poseida Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$59.9M, a 57.6% increase from 2021.
- Poseida Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$141M, a 11.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)